Chapter 7 Part 2 Flashcards
Key factors that contribute to likelihood of metastasis
lack of differentiation, aggressive local invasion, rapid growth, large size
expansion of benign tumor vs. localized invasion of malignant tumors
benign tumor will grow in size without initiating growth in other tissues; malignant tumors can penetrate blood vessels, lymphatics, body cavities and have the potential to metastasize in other tissues
Major pathways of dissemination via which a malignancy can metastasize
direct seeding (lack of barrier), lymphatic spread, hematogenous spread
Lymphatic spread
most common pathway for initial dissemination of carcinomas, spreads via lymphatic vessels to nodes
Sentinel node
first node in regional lymphatic basin that receives lymph flow from the primary tumor, must be biopsied to check for metastatic growth
Hematogenous spread of CA
typical of sarcomas, often venous spread to capillary beds, especially liver and lungs
CAs most commonly spread via hematogenous spread
carcinomas of thyroid and prostate, hepatocellular carcinomas and renal cell carcinomas
definition of incidence
number of new cases that develop over a period of time
definition of prevalence
number of cases present in a specific population at a given time
definition of mortality
measure of death frequency
Incidence of CA cases in 2008
12.7 million, 7.6 million deaths
Incidence and mortality of CA by 2030
21.4 million cases, 13.2 million deaths
Cancer incidence for men
Prostate (28%), lung (14%), colon and rectum (8%)
Cancer mortality for men
Lung (28%), prostate (10%), colon and rectum (8%)
Cancer incidence for women
Breast (29%), lung (13%), colon and rectum (8%)
Cancer mortality for women
Lung (26%), breast(15%), colon and rectum (9%)
Distribution of prostate and breast CA
most prevalent in developed nations (North America, south America, Australia, Europe)
Reasons for differing CA incidences
infectious agents, smoking, alcohol consumption, diet, obesity, reproductive history and age, environmental carcinogens
Influence of age in CA development
more common in later years of life due to accumulation of somatic mutations associated with emergence of neoplasms and decline in immune competence
CA associated with arsenic
lung and skin carcinoma
CA associated with asbestos
lung, esophageal, gastric, and colon carcinoma; mesothelioma
CA associated with benzene
acute myeloid leukemia
CA associated with beryllium
lung carcinoma
CA associated with cadmium
prostate carcinoma
CA associated with chromium
lung carcinoma
CA associated with nickel compounds
Lung and esophageal carcinomas
CA associated with radon
lung carcinoma
CA associated with vinyl chloride
hepatic angiosarcoma
CA associated with IBS
colorectal carcinoma
CA associated with Lichen sclerosis
vulvar squamous cell carcinoma
CA associated with pancreatitis
pancreatic carcinoma
CA associated with chronic cholecystitis
gallbladder CA
CA associated with reflux esophagitis
esophageal carcinoma
CA associated with Sjogren syndrome, Hashimoto’s
MALT lymphoma
CA associated with cholangitis
cholangiocarcinoma
CA associated with gastritis
MALT lymphoma, gastric adenocarcinoma
CA associated with hepatitis
hepatocellular carcinoma
CA associated with osteomyelitis
carcinoma in draining sinuses
CA associated with chronic cervicitis
cervical carcinoma
CA associated with chronic cystitis
bladder carcinoma
Examples of CA causing agents
alcohol, bile acids, gastric acid, liver flukes, hep B and C, HPV, bacterial infection
Precursor lesions
localized morphologic changes associated with high risk CA
Examples of precursor lesions in chronic inflammation
Barretts esophagus, squamous metaplasia, colonic metaplasia
Precursor lesion in noninflammatory hyperplasias
endometrial hyperplasia
CA associated with leukoplakia
thickening of squamous epithelium in oral cavity, vulva, penis gives rise to squamous carcinoma
What percentage of CAs are associated with sporadic mutations?
95%
Increased likeliness of breast cancer with BRCA mutation
3x
Potential environmental factors that may be linked to breast CA development
increased reproductive/maternal age